Table 2
Analysis of the echocardiograms of the patients before, during and after chemotherapy
| Clinical characteristics | Before chemotherapy (
̄±s) | During chemotherapy (
±s) | After chemotherapy (
±s) | F(B) or χ² | P12 | P13 | P23 |
| LVEF (%) | 64.458±3.713 | 64.169±3.314 | 63.992±3.636 | 0.598(B) | 0.896 | 0.700 | 0.971 |
| LAMAD (mm) | 31.508±3.486 | 31.915±3.988 | 31.966±4.118 | 0.610(B) | 0.789 | 0.734 | 1.000 |
| RAMD (mm) | 29.619±2.276 | 29.644±2.567 | 29.542±2.395 | 0.945(B) | 1.000 | 0.992 | 0.985 |
| LVEDD (mm) | 42.203±3.014 | 42.115±3.346 | 41.915±3.107 | 0.773(B) | 0.995 | 0.851 | 0.951 |
| LVESD (mm) | 26.822±2.797 | 27.000±2.897 | 27.195±2.596 | 0.585(B) | 0.950 | 0.640 | 0.929 |
| RVID (mm) | 14.627±1.642 | 14.814±2.335 | 15.093±3.320 | 0.363 | 0.571 | 0.158 | 0.396 |
P12, P13 and P23 represent the calculation results of corresponding tests for indicators before and during chemotherapy, before and after chemotherapy, and during and after chemotherapy, respectively.
LAMAD, left atrial maximum anteroposterior diameter; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; RAMD, right atrial mediolateral diameter; RVID, right ventricular internal dimension.